Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System

ConditionType1diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHenan University of Science and Technology

About this trial

The study is to evaluate the accuracy and safety of a novel real-time CGM system among adult patients with type 1 diabetes mellitus with respect to YSI reference venous plasma sample measurements.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Diagonsed with T1DM or T2DM

Venous blood sampling access can be established in the forearm

Capable of independently reading instructions and complying with the clinical trial requirements

Disqualifiers

Severe hypoglycemia within the past 6 month

Heart failure or hemiplegic sequelae due to prior cerebrovascular disease

Severe skin conditions at the sensor wear site

Extensive systemic skin disorders

Trial design

Treatments tested in this trial

  • GS3 CGM

Treatment groups

82 Participants
are divided into 1 treatment group

Sponsors and collaborators

Henan University of Science and Technology

Lead sponsor

The First Affiliated Hospital of Henan University of Science and Technology

Sponsor institution